InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.

InMode Ltd.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on InMode (INMD – Research Report) and Elanco Animal ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	INMD	$14.13	+2.24%	603.23K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	INMD	$14.13	+2.2%	603.23K
3
4
5
6

INMD

INMD

Get InMode Ltd. Data in Excel

Get InMode Ltd. Data in Excel